Overview

Quetiapine XR in Schizophrenic Patients

Status:
Terminated
Trial end date:
2010-08-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to determine the effect of Quetiapine in patients with schizophrenia induced by cannabis abuse.
Phase:
Phase 3
Details
Lead Sponsor:
Hannover Medical School
Collaborators:
AstraZeneca
Hannover Clinical Trial Center GmbH
Treatments:
Quetiapine Fumarate